124 related articles for article (PubMed ID: 38159981)
21. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
22. Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.
Taira T; Nozawa H; Kawai K; Sasaki K; Murono K; Emoto S; Kishikawa J; Ozawa T; Yokoyama Y; Abe S; Nagai Y; Anzai H; Sonoda H; Ishihara S
Oncology; 2022; 100(2):82-88. PubMed ID: 34818659
[TBL] [Abstract][Full Text] [Related]
23. Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study.
Song JH; Kim SH; Lee JH; Cho HM; Kim DY; Kim TH; Kim SY; Baek JY; Oh JH; Nam TK; Yoon MS; Jeong JU; Kim K; Chie EK; Jang HS; Kim JS; Kim JH; Kang KM
Radiother Oncol; 2016 Feb; 118(2):387-92. PubMed ID: 26763136
[TBL] [Abstract][Full Text] [Related]
24. Oncologic outcomes after radical surgery following preoperative chemoradiotherapy for locally advanced lower rectal cancer: abdominoperineal resection versus sphincter-preserving procedure.
Kim JS; Hur H; Kim NK; Kim YW; Cho SY; Kim JY; Min BS; Ahn JB; Keum KC; Kim H; Sohn SK; Cho CH
Ann Surg Oncol; 2009 May; 16(5):1266-73. PubMed ID: 19224287
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
McCoy MJ; Hemmings C; Hillery S; Penter C; Bulsara MK; Zeps N; Platell CF
ANZ J Surg; 2017 Dec; 87(12):E233-E239. PubMed ID: 26631340
[TBL] [Abstract][Full Text] [Related]
26. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study.
Bosch SL; Verhoeven RHA; Lemmens VEPP; Simmer F; Poortmans P; de Wilt JHW; Nagtegaal ID
Virchows Arch; 2019 Dec; 475(6):745-755. PubMed ID: 31463728
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy does not improve cancer-specific survival for pathologic stage II/III rectal adenocarcinoma after neoadjuvant chemoradiotherapy and surgery: evidence based on long-term survival analysis from SEER data.
Liao H; Zeng T; Xie X; Li J; Li D; KejinYan ; Chen F; Zhu H
Int J Colorectal Dis; 2023 May; 38(1):134. PubMed ID: 37199862
[TBL] [Abstract][Full Text] [Related]
28. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review.
Fadel MG; Ahmed M; Malietzis G; Pellino G; Rasheed S; Brown G; Tekkis P; Kontovounisios C
Cancer Treat Rev; 2022 Sep; 109():102419. PubMed ID: 35714574
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer.
Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY
Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665
[TBL] [Abstract][Full Text] [Related]
30. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
[TBL] [Abstract][Full Text] [Related]
31. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
[TBL] [Abstract][Full Text] [Related]
32. Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.
Ecker BL; Paulson EC; Datta J; Jeganathan AN; Aarons C; Kelz RR; Mahmoud NN
J Surg Oncol; 2015 Sep; 112(4):415-20. PubMed ID: 26250884
[TBL] [Abstract][Full Text] [Related]
33. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
34. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
35. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
37. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
39. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
Tan S; Ou Y; Huang S; Gao Q
Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
[TBL] [Abstract][Full Text] [Related]
40. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]